Cancer is the leading cause of death in the world and despite the prevalence of diagnostic testing most cancers are found at later stages when options for treatment are limited.
In 2021, a health care company called Grail focused on early detection of multiple cancers by developing the Galleri test.
This is a simple blood test that offers a new hope for uncovering 55 cancers among patients with undiagnosed cancers. The test is available exclusively at highly-advanced medical centers such as WellMax, where patients come for individualized, state-of-the-art care.
This test caught the attention of WellMax founder, Daniel Cosgrove, MD. "I've spent a lot of time reviewing the Galleri test with a scientist at Grail. There are always issues of sensitivity and specificity with a test like.